世界の前立腺特異抗原（PSA）バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4772 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、前立腺特異抗原（PSA）バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血、精液、尿）、用途別市場規模（診断、創薬、個別化医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・前立腺特異抗原（PSA）バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・前立腺特異抗原（PSA）バイオマーカーの種類別市場規模と予測2016-2027（血、精液、尿） ・前立腺特異抗原（PSA）バイオマーカーの用途別市場規模と予測2016-2027（診断、創薬、個別化医療、その他） ・前立腺特異抗原（PSA）バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・前立腺特異抗原（PSA）バイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺特異抗原（PSA）バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺特異抗原（PSA）バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺特異抗原（PSA）バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Siemens Healthcare、DiaSorin、Roche、Tosoh Bioscience、Fujirebio、BodiTech、GE Healthcare、Endocare、Quest Diagnostics、Bio-Rad Laboratories、QIAGEN、Myriad RBM） ・結論

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis.

Market Analysis and Insights: Global Prostate Specific Antigen (PSA) Biomarker Market
The global Prostate Specific Antigen (PSA) Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Specific Antigen (PSA) Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Specific Antigen (PSA) Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Specific Antigen (PSA) Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Specific Antigen (PSA) Biomarker market.

Global Prostate Specific Antigen (PSA) Biomarker Scope and Market Size
Prostate Specific Antigen (PSA) Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood
Semen
Urine

Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
BodiTech
GE Healthcare
Endocare
Quest Diagnostics
Bio-Rad Laboratories
QIAGEN
Myriad RBM

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood
1.2.3 Semen
1.2.4 Urine
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Perspective (2016-2027)
2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Regions
2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Specific Antigen (PSA) Biomarker Industry Dynamic
2.3.1 Prostate Specific Antigen (PSA) Biomarker Market Trends
2.3.2 Prostate Specific Antigen (PSA) Biomarker Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Biomarker Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2016-2021)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
3.4 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2020
3.5 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2022-2027)

5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
6.2.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
6.2.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
6.2.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
6.3.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
6.3.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
6.3.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
6.4.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
6.4.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type
7.2.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application
7.3.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country
7.4.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type
8.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application
8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region
8.4.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
9.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
9.2.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
9.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
9.3.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
9.4 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
9.4.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type
10.2.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application
10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country
10.4.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
11.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.2.5 Siemens Healthcare Recent Development
11.3 DiaSorin
11.3.1 DiaSorin Company Details
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
11.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.3.5 DiaSorin Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Tosoh Bioscience
11.5.1 Tosoh Bioscience Company Details
11.5.2 Tosoh Bioscience Business Overview
11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
11.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.5.5 Tosoh Bioscience Recent Development
11.6 Fujirebio
11.6.1 Fujirebio Company Details
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
11.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.6.5 Fujirebio Recent Development
11.7 BodiTech
11.7.1 BodiTech Company Details
11.7.2 BodiTech Business Overview
11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
11.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.7.5 BodiTech Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.8.5 GE Healthcare Recent Development
11.9 Endocare
11.9.1 Endocare Company Details
11.9.2 Endocare Business Overview
11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
11.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.9.5 Endocare Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
11.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.10.5 Quest Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
11.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 QIAGEN
11.12.1 QIAGEN Company Details
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
11.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.12.5 QIAGEN Recent Development
11.13 Myriad RBM
11.13.1 Myriad RBM Company Details
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
11.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
11.13.5 Myriad RBM Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood
Table 3. Key Players of Semen
Table 4. Key Players of Urine
Table 5. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2016-2021)
Table 9. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2022-2027)
Table 11. Prostate Specific Antigen (PSA) Biomarker Market Trends
Table 12. Prostate Specific Antigen (PSA) Biomarker Market Drivers
Table 13. Prostate Specific Antigen (PSA) Biomarker Market Challenges
Table 14. Prostate Specific Antigen (PSA) Biomarker Market Restraints
Table 15. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players (2016-2021)
Table 17. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2020)
Table 18. Ranking of Global Top Prostate Specific Antigen (PSA) Biomarker Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
Table 22. Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2016-2021)
Table 26. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Prostate Specific Antigen (PSA) Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application (2016-2021)
Table 30. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Prostate Specific Antigen (PSA) Biomarker Product
Table 65. Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Siemens Healthcare Company Details
Table 68. Siemens Healthcare Business Overview
Table 69. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product
Table 70. Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 71. Siemens Healthcare Recent Development
Table 72. DiaSorin Company Details
Table 73. DiaSorin Business Overview
Table 74. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product
Table 75. DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 76. DiaSorin Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Prostate Specific Antigen (PSA) Biomarker Product
Table 80. Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Tosoh Bioscience Company Details
Table 83. Tosoh Bioscience Business Overview
Table 84. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product
Table 85. Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 86. Tosoh Bioscience Recent Development
Table 87. Fujirebio Company Details
Table 88. Fujirebio Business Overview
Table 89. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product
Table 90. Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 91. Fujirebio Recent Development
Table 92. BodiTech Company Details
Table 93. BodiTech Business Overview
Table 94. BodiTech Prostate Specific Antigen (PSA) Biomarker Product
Table 95. BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 96. BodiTech Recent Development
Table 97. GE Healthcare Company Details
Table 98. GE Healthcare Business Overview
Table 99. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 100. GE Healthcare Recent Development
Table 101. Endocare Company Details
Table 102. Endocare Business Overview
Table 103. Endocare Prostate Specific Antigen (PSA) Biomarker Product
Table 104. Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 105. Endocare Recent Development
Table 106. Quest Diagnostics Company Details
Table 107. Quest Diagnostics Business Overview
Table 108. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product
Table 109. Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 110. Quest Diagnostics Recent Development
Table 111. Bio-Rad Laboratories Company Details
Table 112. Bio-Rad Laboratories Business Overview
Table 113. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product
Table 114. Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 115. Bio-Rad Laboratories Recent Development
Table 116. QIAGEN Company Details
Table 117. QIAGEN Business Overview
Table 118. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product
Table 119. QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 120. QIAGEN Recent Development
Table 121. Myriad RBM Company Details
Table 122. Myriad RBM Business Overview
Table 123. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product
Table 124. Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021) & (US$ Million)
Table 125. Myriad RBM Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Blood Features
Figure 3. Semen Features
Figure 4. Urine Features
Figure 5. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2020 VS 2027
Figure 6. Diagnostics Case Studies
Figure 7. Drug Discovery Case Studies
Figure 8. Personalized Medicine Case Studies
Figure 9. Others Case Studies
Figure 10. Prostate Specific Antigen (PSA) Biomarker Report Years Considered
Figure 11. Global Prostate Specific Antigen (PSA) Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions: 2020 VS 2027
Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2022-2027)
Figure 15. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players in 2020
Figure 16. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue in 2020
Figure 18. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2016-2021)
Figure 19. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2022-2027)
Figure 20. North America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
Figure 22. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
Figure 23. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
Figure 24. United States Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
Figure 28. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
Figure 29. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
Figure 30. Germany Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2016-2027)
Figure 40. China Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
Figure 48. Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
Figure 49. Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
Figure 50. Mexico Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Country (2016-2027)
Figure 56. Turkey Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 60. Siemens Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 61. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 63. Tosoh Bioscience Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 64. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 65. BodiTech Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 66. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 67. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 68. Quest Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 70. QIAGEN Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 71. Myriad RBM Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---